Editorial

Treating Addiction, Seriously

Authors: John B. Standridge, MD

Abstract

The scope of the addiction problem is enormous. Alcohol abuse in the United States is particularly common, with 22.6% of Americans reporting binge drinking and 6.8% reporting repetitious heavy drinking within the past 30 days. A well-crafted, wonderfully phrased and readable manuscript, such as the article by Dr. Christopher Shea, serves us well as a call to arms. From the Neurobiologic Basis of Alcohol Dependence to Pharmacologic Treatment Strategies: Bridging the Knowledge Gap1 is hugely important in concept and topic. It remains difficult for many health professionals to accept and understand substance use disorders as an illness rather than a personal weakness. Nonetheless, based on decades of research, it is apparent that the brain of the individual who has a substance use disorder may be different in fundamental ways from the brains of others. Changes in gene expression, metabolism, neurotransmission, and responsiveness to environmental cues may produce compulsive substance seeking and substance use, with disruption of cognitive, emotional, and social behaviors.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Shea CW. From the neurobiologic basis of alcohol dependency to pharmocologic treatment strategies: bridging the knowledge gap South Med J 2008;101:179–185.